Local anaesthetic agents

Similar documents
Overview. Normally, the process is completely reversible.

Local Anesthetics. Xiaoping Du Room E417 MSB Department of Pharmacology Phone (312) ;

THE PHARMACOLOGY OF LOCAL ANAESTHETIC AGENTS Dr J M Tuckley, Department of Anaesthetics, Royal Devon and Exeter NHS Trust

Local Anesthetics. Dr. Hiwa K. Saaed, PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Local anesthetics (LAs)

Local anaesthetics. Dr JM Dippenaar

Regional Anesthesia. Fatiş Altındaş Dept. of Anesthesiology

3.2 Local Anaesthetic Techniques. Local anaesthetic pharmacology and toxicity. LA Structure. Most are weak bases - esters or amides - of the form:

Local Anaesthetics. Hamed Akhlaghi ED Registrar Bendigo Hospital

Local Anesthetics. ester or amide linkage. lipophilic. hydrophilic MII Susan E. Robinson O CH 2 CH 2 N CH 2 CH 3 H 2 N

log = pk a -ph log = = 0.2 log = = 1.1 log [1.5] = 0.2 log [12.6] = 1.1 Local anesthetics act in a frequency-dependent manner

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Local Anaesthetic Pharmacology 11/07/05 Dr Hilary Edgcombe, Dr Graham Hocking John Radcliffe Hospital, Oxford, UK

Local Anesthetics. Introduction and History

LOCAL ANAESTHESIA TOXICITY

Slide 1. Slide 2. Slide 3. Local Anesthetics. Local Anesthetics. Lesson 9.1. History and Purpose of Anesthetics. Chapter 9

Physiology and Pharmacology

Data Sheet 3% Citanest DENTAL with Octapressin

Pharmacology of Local Anaesthetic drugs

Core Safety Profile. Date of FAR:

Prevention and Treatment Patrick Levelle, MD

LIDOCAINE HYDROCHLORIDE TOPICAL SOLUTION USP 4%

MARCAINE 0.5% MARCAINE ADRENALINE 0.5% ASTRAZENECA

Surgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Prescribing Information. Carbocaine 1% Carbocaine 2%

NAROPIN ASTRAZENECA. Naropin 2 mg/ml, 7.5 mg/ml and 10 mg/ml Ropivacaine hydrochloride Solution for injection Composition

General Anesthesia. My goal in general anesthesia is to stop all of these in the picture above (motor reflexes, pain and autonomic reflexes).

Core Safety Profile. Pharmaceutical form(s)/strength: 5mg/ml and 25 mg/ml, Solution for injection, IM/IV FI/H/PSUR/0010/002 Date of FAR:

Regional Anaesthesia of the Thoracic Limb

Chapter 19. Media Directory. Topical (Surface) Anesthesia. Spinal Anesthesia. Nerve-Block Anesthesia. Infiltration (Field-Block) Anesthesia

1. EPINEPHRINE 2. PREDNISONE 3. BENADRYL 4. HYALURONIDASE 5. BABY ASPIRIN 6. NITROPASTE 7. VIAGRA 8. CANNULAS. Must Haves for Injection Safety

PHARMACOLOGY OF LOCAL ANAESTHETIC AGENTS

peri-operative care series

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

ANALGESIA and LOCAL ANAESTHESIA. Professor Donald G. MacLellan Executive Director Health Education & Management Innovations

Duration of Action/Which Local Anesthetics to Use. Stephan Klessinger, Germany

Mepivacaine hydrochloride

Regional Anesthesia. procedure if required. However, many patients prefer to receive sedation either during the

4/15/2018. Most frequently used medication in dentistry > 6 million carpules per week 300 million carpules per year

COMPARATIVE ANAESTHETIC PROPERTIES OF VARIOUS LOCAL ANAESTHETIC AGENTS IN EXTRADURAL BLOCK FOR LABOUR

LocalAnaesthesia. & Pain Management. RW Nieuwveld. Dept. of Anaesthesia University of Cape Town

CHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Local Anaesthetic Systemic Toxicity (LAST)

Mepivacaine Hydrochloride Injection USP, 3%

SUMMARY OF PRODUCT CHARACTERISTICS

Nervous System. 2. Receives information from the environment from CNS to organs and glands. 1. Relays messages, processes info, analyzes data

Guidelines for Anticoagulation and Anesthesia for Breast Interventions

SCANDINIBSA 30 mg/ml is indicated for local dental anaesthesia (by infiltration and nerve blockade) in adults and children aged 4 years or older.

WITH ISOBARIC BUPIVACAINE (5 MG/ML)

General anesthesia. No single drug capable of achieving these effects both safely and effectively.

Neurons, Synapses, and Signaling

Neuromuscular Blockers

General Anesthesia. Mohamed A. Yaseen

SUMMARY OF PRODUCT CHARACTERISTICS

+ 40 mv. Resting Membrane. Potential. Time (msec) Depolarization! Hyperpolarized. Na + equilibrium. Action. Potential. Threshold.

A concise review of the basic biology and pharmacology of local analgesia

The complications of local analgesia

Chapter 11: Functional Organization of Nervous Tissue

(PP XI) Dr. Samir Matloob

NEUROMUSCULAR BLOCKING AGENTS

BUPIVACAINE INJECTION BP

Emla (lidocaine 2.5% and prilocaine 2.5%), Lidocaine Topical 5%, Pliaglis Cream (lidocaine 7% and tetracaine 7%), Tetravex Gel (tetracaine 2%)

LOCAL ANESTHETICS: A PRACTICAL REVIEW FOR SEDATION DENTISTRY

Axon Nerve impulse. Axoplasm Receptor. Axomembrane Stimuli. Schwann cell Effector. Myelin Cell body

4/15/2018. Patient concerns needle pinch in mouth g single stick or multiple anxiety, pain, & burning on injection

PRODUCT MONOGRAPH. SENSORCAINE Bupivacaine Hydrochloride Injection USP 0.25% (2.5 mg/ml) and 0.5% (5 mg/ml) polyamps and vials.

Naropin 7.5 mg/ml solution for injection

Local Anesthetic for Infiltration and Nerve Block. Lidocaine Hydrochloride Injection, USP is a local anesthetic which is a sterile,

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

211MDS Pain theories

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

CARPAL TUNNEL RELEASE BLOCK Author John Hyndman

Sign up to receive ATOTW weekly

MINIMS OXYBUPROCAINE EYE DROPS

Regional Anaesthesia for Children

10.1: Introduction. Cell types in neural tissue: Neurons Neuroglial cells (also known as neuroglia, glia, and glial cells) Dendrites.

Neosynephrine. Name of the Medicine

Structural Organization of Nervous System

MD (Anaesthesiology) Title (Plan of Thesis) (Session )

Ganglion blocking agents

ASA Closed Claims Project: Regional Anesthesia Claims 1990 or later Lorri A. Lee MD Department of Anesthesiology University of Washington, Seattle, WA

LIDOCAINE- lidocaine ointment VITRUVIAS THERAPEUTICS Lidocaine Ointment USP, 5% For topical us e only Do not use in the eyes Rx Only

3. PHARMACEUTICAL FORM Solution for injection Clear, colourless, sterile, isotonic, isobaric aqueous solution for injection with a ph of 4.0 to 6.0.

Functions of Nervous System Neuron Structure

Neuromuscular Junction

BENEFITS OF NEURAL BLOCKADE

MOLECULAR AND CELLULAR NEUROSCIENCE

The Nervous System. Functions of the Nervous System input gathering To monitor occurring inside and outside the body Changes =

Corporate Medical Policy

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

PRODUCT INFORMATION NAME OF THE MEDICINE

ALS MODULE 7 Pharmacology

B U J O D. Original Research

MINIMS AMETHOCAINE EYE DROPS

Topical Local Anaesthesia

PRODUCT MONOGRAPH. SENSORCAINE Bupivacaine Hydrochloride Injection USP 0.25% (2.5 mg/ml) and 0.5% (5 mg/ml) polyamps and vials

PRODUCT INFORMATION MINIMS OXYBUPROCAINE EYE DROPS NAME OF THE MEDICINE. Oxybuprocaine (benoxinate) hydrochloride. Chemical Structure

THE NERVOUS SYSTEM. Neurons & Impulses

Arrhythmias. 1. beat too slowly (sinus bradycardia). Like in heart block

Transcription:

Local anaesthetic agents 1

Lecture Objectives: Awn khawaldeh 1.Definition 2. Classification of Local Anaesthetic Agents 2.1. Comparison between the two Classes. 3. Mode of action 4. composition of Local Anaesthetic Agents 2

Lecture Objectives Lama Nedal 5. Addition of Vasoconstrictors 5.1. Indications and Contraindications and Dosage. 5.2. How can I prepare Adrenaline 1:200000? 6. Clinical uses of local anesthetic agents Ehab Kharabsheh 7. Lidocaine 8.Toxicity (Causes, Prevention and Treatment) 8.1. Systemic Toxicity 3

The Pharmacology of Local Anaesthetic Agents (LA) Awn khawaldeh A substances which reversibly inhibits nerve conduction when applied directly to tissues, thereby producing temporary loss of sensation in a limited area. LA will block generation, propagation, and oscillations of electrical impulses in electrically excitable tissue. Classification : The molecule of the clinically useful LA agents consists of 1. A tertiary amine (hydrophilic group) attached to an 2. Aromatic ring (lipophilic group) by an 3. Intermediate chain. 4

There are important practical differences between these 2 groups of LA agents Ester Short duration of action Less intense analgesia Higher risk of hypersensitivity because the metabolism of most ester produce PABA(a known allergen) metabolized by Plasma pseudocholinesterase in blood. Rarely used for Infiltration anesthesia But useful for topical anesthesia on mucous membranes. Amide longer lasting analgesia. Produce more intense analgesia. Rarely cause hypersensitivity reactions Not hydrolyzed by Plasma Cholinesterase, more slowly metabolized by liver microsomal P 450 enzymes. For there reasons amides are more commonly used 5

Classification of LA Agents There are 2 classes of local anaesthetic drugs defined by the nature of the intermediate chain. Ester Cocaine Procaine Chlorprocaine Tetracaine Amides Bupivacaine Lidocaine Mepivacaine Prilocaine Ropivacaine All LA cross BBB and placenta 6

Common Uses Of Local Anaesthetics: Dentistry Dermatology Excision Spinal Anaesthesia 7

Mode of action-membrane structure 8

Mode of action After injection, the tertiary amine base is liberated by the relatively alkaline ph of tissue fluids: These effects are due to blockade of sodium channels, thereby impairing sodium ion flux, across the membrane. Na+ ion channels are blocked to prevent the transient increase in permeability of the nerve membrane to Na+ that is required for an action potential When propagation of action potentials is prevented, sensation cannot be transmitted from the source of stimulation to the brain Delivery techniques include topical administration, infiltration, peripheral nerve blocks, and neuraxial (spinal, epidural, or caudal) blocks. 9

ACTIONS OF LA - LOCAL All LAs have effects on nerves acting via Na+ channel - sensory endings, nerve trunks, NM junctions, ganglion and receptors. Sensory and Motor fibers are sensitive - depends on fiber size, type, and myelination;: Smaller fibers are more sensitive than larger ones. Myelinated nerves are blocked earlier than non-myelinated ones. Autonomic fibers are more susceptible than somatic ones. *Order of blockade in general is : Pain - temperature - touch - deep pressure. 10

IMPORTANT CLINICAL PROPERTIES OF LOCAL ANESTHETICS 1. pka = ONSET pka = ph at which 50% of drug is ionized Only the nonionized form crosses into the nerve cell ( inside the axon will become ionized so block Na channel) 2. ph influence Decrease in ph (solution more acidic ) shifts equilibrium toward the ionized form, delaying the onset action. -Presence of Pus and inflammation will retard the action of LA. 3. LIPID SOLUBILITY = Potency Higher solubility <=> can use a lower concentration and reduce potential for toxicity [LA], because 90% of the nerve cell membrane is composed of lipid. 4. PROTEIN BINDING = Duration Bupivacaine 95% Lidocaine 65% 11

Composition of LA Solution Lignocaine Hcl ( Anesthetic) Adrenaline (Vasoconstrictor) (don t explain Lama will do) Sodium metabisulphite (Reducing Agent) methyl parahydroxybenzoate (Preservative) Thymol (Fungicide) (in the past some solution tend to become cloudy duo to the proliferation of minute fungi ) Salts (NaCl) (Isotonicity)(minimize discomfort during injection) Distilled Water (Vehicle) OR Ringer s Lactate reducing agent (e.g. sodium metabisulphite) to enhance the stability of added vasoconstrictors(unstable on solution) Preservative for stability of anesthetic 12

What does 1% Lidocaine mean? The dilute preparations are presented as percentage (%)solutions of LA. A solution expressed as 1% contains 1g substance in each 100mls Lidocaine 1 % means a 1:100 dilution. That is 1 g : 100ml; That is 1000 mg : 100ml That means 10 mg : 1ml. The number of mg/ml can easily be calculated by multiplying the percentage strength by 10. - Therefore a 0.25% solution of lidocaine contains 2.5mg/ml of solution (10 * 0.25=2.5 mg /ml) 13

Q 2 ml of Lidocaine 1% with 1:100,000 epinephrine has how many mg of lidocaine and how many mg of epinephrine? 1-2ml of the solution will contain 2* (10mg) = 20 mg of lidocaine 2- Epinephrine 1:100,000 means 1g : 100, 000 ml 1000mg : 100,000 ml, or 1mg : 100ml 0.01mg : 1ml, or 2ml of the solution will contain 2* (0.01mg) = 0.02mg of epinephrine 2ml of lidocaine 1% and Epinephrine 1:100,000 has 20mg of lidocaine and 0.02mg of epineprine 14

Lama nedal shatat vasoconstrictors Most LA produce some degree of vasodilation, and they may be rapidly absorbed after local injection

Why we add vasoconstrictors Addition of a vasoconstrictor to a local anesthetic may have several beneficial effects: 1)a decrease in the peak plasma concentration of the local anesthetic agent, so decrease the systemic toxicity and increase the safety margin of local anaesthetics by reducing their rate of absorption 2)increase in the duration and the quality of anesthesia 3) reduction of the minimum concentration of anesthetic needed for nerve block 4) decrease of blood loss during surgical procedure Adrenaline is the most commonly used vasoconstrictor in concentrations ranging from 1 in 80,000 to 1 in 300,000.

How can I prepare Adrenaline 1:200000? >>>Adrenaline dilution 1:200000 means 1 g in 200000 ml = 1000 mg in 200000 ml 1 mg in 200 ml = 0.1 mg in 20 ml >>>How can I prepare Adrenaline 1:80000.. = 0.1 mg in 8 ml

contraindication for Adrenaline containing local anaesthetic agents: Absolute contraindication (should never be used) for: 1.infiltration around end-arteries An end artery (or terminal artery) is an artery that is the only supply of oxygenated blood to a portion of tissue. i.e. ring block of fingers, penis or other areas with a terminal vascular supply as the intense vasoconstriction may lead to severe ischaemia and necrosis

2. Intravenous regional anaesthesia (IVRA) an anesthetic technique on the body's extremities where a local anesthetic is injected intravenously and isolated from circulation in a target area. A tourniquet is applied to a limb proximal to the planned surgical site, and a local anesthetic is injected intravenously distal to the tourniquet. Relative contraindication: 1.Patient with severe hypertension Tourniquet use is associated with an increase in systolic blood pressure over time79; this increase may be excessive, particularly in hypertensive patients.8 2.General anaesthesia with halothane Reducee bp dec pulse rate >ischemia

Clinical Uses of Local Anaesthetics 1. Topical Anaesthesia 2. Infiltration Anaesthesia 3. Peripheral Nerve Blockade 4. Intravenous regional anaesthesia (IVRA) 5. Spinal Anaesthesia 6. Extradural Anaesthesia

1: Topical Anaesthesia LA may be applied to the skin, the eye, the ear, the nose and the mouth as well as other mucous membranes. most useful and effective: Lidocaine (i.e.gel 2%) and prilocaine(i.e.emla) 2: Infiltration Anaesthesia provide anaesthesia for minor surgical procedures. commonly used Amide LA are (Lidocaine prilocaine,mepivacaine and Bupivacaine)., The site of action is at unmyelinated nerve endings and onset is almost immediate

3: Intravenous regional anaesthesia (IVRA) IVRA (BIER s Block) analgesia for minor surgical procedures. The local anaesthetic agent is injected into a vein of a limb that has been previously exsanguinated and occluded by a tourniquet. The site of action is probably the unmyelinated nerve fibres, Prilocaine and Ldocaine are commonly used. Bupivacaine and etidocaine should never be used for IVRA! They are significantly protein bound and once the tourniquet is released there is a risk of cardiotoxicity. Several deaths have been reported during IVRA with bupivacaine.

4: Peripheral Nerve Blockade : Regional anesthetic procedures that inhibit conduction in fibers of the peripheral nervous system. It can be devided into: Minor nerve blocks involve the blocking of single nerve entities such as the inferior alveolar nerve, mental nerve, ulnar or radial nerve. Major nerve blocks involve the blocking of deeper nerves or trunks with a wide dermatomal distribution (e.g. brachial plexus blockade). The commonly used LA agents are: Lidocaine, prilocaine, mepivacaine, and bupivacaine.

5: Extradural Anaesthesia:LA agent injected in the epidural space between the dura mater and the Lig.Flavum. usually used mainly isobaric Bupivacaine 0.5% or lidocaine (2.0%) 6.: Spinal Anaesthesia injction directly into the cerebrospinal fluid (subarachnoid space) produces spinal anaesthesia. commonly used : mainly hyperbaric Bupivacaine 0.5% or lidocaine (5%)

Ehab Kharabsheh Lidocaine Lidocaine, the first amino amide-type local anesthetic, was developed first by Löfgren and Lundqvist in 1943 and first marketed in 1948. Lidocaine Solutions 0.5, 1, 1.5 and 2% contain lidocaine hydrochloride 5, 10, 15 and 20 mg/ml, respectively. Solutions with epinephrine contain (1:100,000) or 0 (1:200,000) epinephrine. 26

Pharmacology Half life: (~90 min) Distribution: Lipo-philic, widely distributed into body ph of plain solution-6.5 ph of vasoconstrictor containing solution-5.0-5.5 Onset of action rapid Pregnancy clissification-b Effective dental concentration-2% Protein binding: 60-80 % 27

Lidocaine Lidocaine use in anesthesia can be explained by the fact that it alters depolarization in neurons, by blocking the fast voltage gated sodium (Na+) channels in the cell membrane. With sufficient blockade, the membrane of the presynaptic neuron will not depolarize and so fail to transmit an action potential, leading to its anesthetic effects. Careful titration allows for a high degree of selectivity in the blockage of sensory neurons, whereas higher concentrations will also affect other modalities of neuron signalling. 28

ACTIONS ON CNS (i) Blocks conduction around a nerve Anaesthesia (ii) Initially causes drowsiness & lethargy (iii) Higher doses cause excitation followed by depression 29

ON CVS Heart Blood vessels Abbreviates Effective Refractory Period Vasodilatation in the injected area 30

ROUTES OF ADMINISTRATION Intravenous injection (sometimes combined with epinephrine) Dermal patch (sometimes combined with prilocaine) Nasal instillation/spray (combined with phenylephrine) Topical gel

Lidocaine Lidocaine is a local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic, and in minor surgery. 32

ADVERSE EFFECTS 33

34

Toxicity from Local Anaesthetic Drugs when excessive blood levels occur. usually due to: 1. Accidental rapid intravenous injection. 2. Rapid absorption, such as from a very vascular site ie mucous membranes. Intercostal nerve blocks will give a higher blood level than subcutaneous infiltration, whereas plexus blocks are associated with the slowest rates of absorption and therefore give the lowest blood levels. 3. Absolute overdose if the dose used is excessive. 35

Signs and Symptoms of LA Toxicity It involves the CNS and CVS. In general (CNS) is more sensitive to LA than the CVS. Therefore CNS manifestations tend to occur earlier. Brain excitatory effects occur before the depressant effects. CNS signs & symptoms Early or mild toxicity: light-headedness, dizziness, tinnitus, circumoral numbness, confusion and drowsiness. Patients often will not volunteer information about these symptoms unless asked. Severe toxicity: tonic-clonic convulsion leading to progressive loss of consciousness, coma, respiratory depression, and respiratory arrest. 36

CVS signs & symptoms Early or mild toxicity: if LA with Adrenaline tachycardia with Hypertension If no Adrenaline : bradycardia with hypotension Severe toxicity: Usually about 4-7 times the convulsant dose needs to be injected before CV collapse occurs. Collapse is due to the depressant effect of the LA acting directly on the myocardium (e.g. Bupivacaine) Severe and intractable arrhythmias can occur with accidental iv injection. 37

Essential Prevention Monitor ECG,O2SAT Secure intravenous access before injection of any dose. Always have adequate resuscitation equipment and drugs available before starting to inject. 38

Treatment: stop the injection and assess the patient. Call for help while treating the patient Treatment is based on the A B C D of Basic Life Support Ensure an adequate airway, give O2 in over facemask. Ventilate the patient if there is inadequate spontaneous respiration Intubation : if the patient is unconscious and unable to maintain an airway. 39

Treatment of circulatory failure with I.V fluids and vasopressors: Ephedrin : If not available or not effective in correcting the hypotension.adrenaline Treat arrhythmias. Start chest compressions if cardiac arrest occurs. Treat Convulsions with anticonvulsant drugs (Diazepam 0.2-0.4mg/kg, Thiopentone 1-4 mg/kg 40